• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals | Telix Pharmaceuticals - 3 year(s) ago

      Our mission is to help patients with cancer live longer with better quality lives

      Source: Telix Pharmaceuticals
      Categories: Latest Headlines, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	Uro_Oncologist
        Uro_Oncologist

        Amazing news, after many years and efforts CAIX becomes a reality! Can’t wait to see innovative trials design with it incorporation! Here’s the link btw https://t.co/I8VfpBd29c https://t.co/x6qdqAnuxB

    • Mashup Score: 0
      Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals | Telix Pharmaceuticals - 3 year(s) ago

      Our mission is to help patients with cancer live longer with better quality lives

      Source: Telix Pharmaceuticals
      Categories: Hem/Oncs, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	cdanicas
        cdanicas

        👏👏 great news for RCC pts!!🎯 TLX250-CDx (93%PPV) as non-invasive tool in Small Renal Mass! Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals https://t.co/g2aEtQAbED

    • Mashup Score: 1
      Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals | Telix Pharmaceuticals - 3 year(s) ago

      Our mission is to help patients with cancer live longer with better quality lives

      Source: Telix Pharmaceuticals
      Categories: Hem/Oncs, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	neerajaiims
        neerajaiims

        Just in: Positive ph3 Zircon imaging study👉@telixpharma CA-9 PET/CT scan has 86% sensitivity & 87% specificity in detecting clear cell RCC non-invasively. Press release👉https://t.co/Ep3OHvhzPP Congrats Brian @KidneyCancerDoc #ColinHyaward @OncoAlert @kidneycan @KidneyCancer https://t.co/FArNWxXmi6 https://t.co/XZp3n9Jtej

    • Mashup Score: 0
      Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals | Telix Pharmaceuticals - 3 year(s) ago

      Our mission is to help patients with cancer live longer with better quality lives

      Source: Telix Pharmaceuticals
      Categories: Latest Headlines, Urology
      Tweet Tweets with this article
      • Profile photo of 	PBarataMD
        PBarataMD

        Hot of the press: Zircon phase III trial meets primary endpoint! Great news for our RCC patients - @neerajaiims @montypal @DrChoueiri @IKCCorg @kcCURE @TelixPharma https://t.co/mdnezNlF07

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings